Mesoblast
MESO
#4330
Rank
โ‚น217.21 B
Marketcap
โ‚น1,687
Share price
3.59%
Change (1 day)
83.44%
Change (1 year)

Mesoblast (MESO) - Total liabilities

Total liabilities on the balance sheet as of June 2025 : โ‚น16.83 Billion

According to Mesoblast 's latest financial reports the company's total liabilities are โ‚น16.83 Billion. A companyโ€™s total liabilities is the sum of all current and non-current debts and obligations.

Mesoblast - Total liabilities on balance sheet (from 2012 to 2025)

Total liabilities by year

Year Total liabilities Change
2024-06-30โ‚น15.73 B14.46%
2023-06-30โ‚น13.75 B5.48%
2022-06-30โ‚น13.03 B7.33%
2021-06-30โ‚น12.14 B-12.99%
2020-06-30โ‚น13.95 B18.36%
2019-06-30โ‚น11.79 B17.66%
2018-06-30โ‚น10.02 B11.65%
2017-06-30โ‚น8.97 B-14.67%
2016-06-30โ‚น10.52 B-47.27%
2015-06-30โ‚น19.95 B1.56%
2014-06-30โ‚น19.64 B30.22%
2013-06-30โ‚น15.08 B12.49%
2012-06-30โ‚น13.41 B21.57%
2011-06-30โ‚น11.03 B14799.32%
2010-06-30โ‚น74.04 M30.58%
2009-06-30โ‚น56.7 M-15.99%
2008-06-30โ‚น67.5 M138.29%
2007-06-30โ‚น28.32 M-86.36%
2006-06-30โ‚น0.20 B116.73%
2005-06-30โ‚น95.83 M

Total liabilities for similar companies or competitors

Company Total liabilities differencediff. Country
NRC Health
NRC
โ‚น10.91 B-35.16%๐Ÿ‡บ๐Ÿ‡ธ USA
Nymox Pharmaceutical
NYMX
โ‚น0.28 B-98.32% Bahamas